Adaptive Biotechnologies Corp:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Adaptive Biotechnologies Corp - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10558
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:29
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Adaptive Biotechnologies Corp (Adaptive) specializes in combining high-throughput sequencing and expert bioinformatics to profile T-cell and B-cell receptors. The company’s product portfolio comprises immunoSEQ and clonoSEQ. It provides immunosequencing platform to laboratories for conducting research in the areas cancers and other immune-mediated diseases. Adaptive develops assays for both clinical diagnosis and therapeutic monitoring for a variety of disorders and conditions. The company translates immunosequencing discoveries into clinical diagnostics and therapeutic development to improve patient care. It works in partnership with institutions and biopharmaceutical companies. The company has offices in South San Francisco, San Diego and New York. Adaptive is headquartered in Seattle, Washington, the US.

Adaptive Biotechnologies Corp – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Adaptive Biotechnologies Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Adaptive Biotechnologies Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Adaptive Biotechnologies Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Adaptive Biotechnologies Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Adaptive Biotechnologies Corp, Medical Devices Deals, 2012 to YTD 2018 9
Adaptive Biotechnologies Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Adaptive Biotechnologies Corp, Pharmaceuticals & Healthcare, Deal Details 12
Venture Financing 12
Adaptive Biotech Raises USD195 Million in Series F Financing 12
Adaptive Biotechnologies Raises USD93.75 Million in Venture Financing 14
Adaptive Biotech Raises US$100 Million In Series D Financing 15
Adaptive Biotech Raises US$20 Million In Series C Financing 16
Sequenta Raises US$20 Million In Series C Financing 17
Adaptive Biotech Raises US$5 Million In Venture Financing 18
Adaptive Biotechnologies Raises US$2.6 Million In Venture Financing 19
Sequenta Raises US$8.5 Million In Venture Financing 20
Partnerships 21
Heat Biologics Enters into Agreement with Adaptive Biotechnologies 21
Pfizer Enters into Research Agreement with Adaptive Biotech 22
Multiple Myeloma Research Foundation Partners with University of Torino and Adaptive Biotech 23
Adaptive Biotechnologies Corp – Key Competitors 24
Adaptive Biotechnologies Corp – Key Employees 25
Adaptive Biotechnologies Corp – Locations And Subsidiaries 26
Head Office 26
Other Locations & Subsidiaries 26
Recent Developments 27
Corporate Communications 27
Feb 13, 2018: Adaptive Biotechnologies Appoints Veteran Molecular Diagnostics Executive Michael Pellini, MD, to Board of Directors 27
Jul 27, 2017: Adaptive Biotechnologies Expands Leadership to Bolster Integration of Immune Profiling into Clinical Care Setting 28
Appendix 29
Methodology 29
About GlobalData 29
Contact Us 29
Disclaimer 29

List of Tables
Adaptive Biotechnologies Corp, Pharmaceuticals & Healthcare, Key Facts 2
Adaptive Biotechnologies Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Adaptive Biotechnologies Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Adaptive Biotechnologies Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Adaptive Biotechnologies Corp, Deals By Therapy Area, 2012 to YTD 2018 8
Adaptive Biotechnologies Corp, Medical Devices Deals, 2012 to YTD 2018 9
Adaptive Biotechnologies Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Adaptive Biotech Raises USD195 Million in Series F Financing 12
Adaptive Biotechnologies Raises USD93.75 Million in Venture Financing 14
Adaptive Biotech Raises US$100 Million In Series D Financing 15
Adaptive Biotech Raises US$20 Million In Series C Financing 16
Sequenta Raises US$20 Million In Series C Financing 17
Adaptive Biotech Raises US$5 Million In Venture Financing 18
Adaptive Biotechnologies Raises US$2.6 Million In Venture Financing 19
Sequenta Raises US$8.5 Million In Venture Financing 20
Heat Biologics Enters into Agreement with Adaptive Biotechnologies 21
Pfizer Enters into Research Agreement with Adaptive Biotech 22
Multiple Myeloma Research Foundation Partners with University of Torino and Adaptive Biotech 23
Adaptive Biotechnologies Corp, Key Competitors 24
Adaptive Biotechnologies Corp, Key Employees 25
Adaptive Biotechnologies Corp, Subsidiaries 26

List of Figures
Adaptive Biotechnologies Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Adaptive Biotechnologies Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Adaptive Biotechnologies Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Adaptive Biotechnologies Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Adaptive Biotechnologies Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Adaptive Biotechnologies Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Adaptive Biotechnologies Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Adaptive Biotechnologies Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Adaptive Biotechnologies Corp, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Adaptive Biotechnologies Corp:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Seylan Bank Plc:企業の戦略・SWOT・財務分析
    Seylan Bank Plc - Strategy, SWOT and Corporate Finance Report Summary Seylan Bank Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Ramba Energy Ltd (R14):石油・ガス:M&Aディール及び事業提携情報
    Summary Ramba Energy Ltd (Ramba Energy), a subsidiary of Redmount Holdings Ltd, is an oil and gas company that offers exploration and production of oil and gas properties in Indonesia. The company provides services such as inbound and outbound transportation activities, seaport and airport cargo han …
  • InviCRO LLC:医療機器:M&Aディール及び事業提携情報
    Summary InviCRO LLC (InviCRO) a subsidiary of Konica Minolta Inc, is a provider of image informatics, engineering and operational services in translational drug discovery and development. The company developed VivoQuant, a DICOM compliant post-processing suite for image data combining fundamental vi …
  • Taiwan Semiconductor Manufacturing Company Limited:企業の戦略・SWOT・財務情報
    Taiwan Semiconductor Manufacturing Company Limited - Strategy, SWOT and Corporate Finance Report Summary Taiwan Semiconductor Manufacturing Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's struct …
  • Capitol Health Ltd (CAJ):医療機器:M&Aディール及び事業提携情報
    Summary Capitol Health Ltd (Capitol Health) is a diagnostic imaging service provider to the healthcare market.. The company offers services such as bone densitomety, computer tomography, cone beam CT, CT angiography, doppler, echocardiography, fluoroscopy, general X-ray, magnetic resonance imaging, …
  • Inox Wind Ltd (INOXWIND):電力:M&Aディール及び事業提携情報
    Summary Inox Wind Ltd (IWL), a subsidiary of Gujarat Fluorochemicals Limited, is a provider of wind energy solutions to independent power producers (IPPs), PSUs, utilities, corporates and retail investors. The company manufactures and markets wind turbine generators; and offers turnkey solutions suc …
  • Groupe Bruxelles Lambert SA (GBLB):企業の財務・戦略的SWOT分析
    Groupe Bruxelles Lambert SA (GBLB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Exact Sciences Corp (EXAS)-製薬・医療分野:企業M&A・提携分析
    Summary Exact Sciences Corp (Exact) is a molecular diagnostic company that focuses on the early detection and prevention of various cancers. The company’s flagship product, Cologuard test is a non-invasive stool-based deoxyribonucleic acid (DNA) screening product indicated for the early detection of …
  • The Dow Chemical Company:企業の戦略・SWOT・財務情報
    The Dow Chemical Company - Strategy, SWOT and Corporate Finance Report Summary The Dow Chemical Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Scholastic Corporation:企業の戦略・SWOT・財務分析
    Scholastic Corporation - Strategy, SWOT and Corporate Finance Report Summary Scholastic Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Bone Therapeutics SA (BOTHE):企業の財務・戦略的SWOT分析
    Summary Bone Therapeutics SA (Bone Therapeutics) is a cell therapy company that develops autologous and allogeneic cell therapy products. The company offers pipeline products such as PREOB, an autologous osteoblastic cell therapy product used for the treatment of osteonecrosis and non-union fracture …
  • James Halstead PLC (JHD):企業の財務・戦略的SWOT分析
    Summary James Halstead PLC (James Halstead) is a manufacturer and distributor of flooring products that provides commercial building equipment and flooring products. The company provides manufacturing of commercial, contract and consumer floorings. It also offers dyeing, finishing and later waterpro …
  • Capital Senior Living Corp (CSU):製薬・医療:M&Aディール及び事業提携情報
    Summary Capital Senior Living Corp (Capital Senior Living) is engaged in providing residential communities for elderly population. The company offers various living accommodations and supportive services including senior living services, independent living services, assisted living services includin …
  • Southern California Edison Co:発電所・企業SWOT分析
    Southern California Edison Co - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key …
  • VSE Corporation (VSEC):企業の財務・戦略的SWOT分析
    VSE Corporation (VSEC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • GATT Technologies BV:製品パイプライン分析
    Summary GATT Technologies BV (GATT Technologies) is a medical technology company, which develops synthetic surgical hemostat and sealant products that control severe bleeding. Its product pipeline includes GATT-Patch for controlling excessive bleeding; GATT-Tape for blocking intestinal anastomotic l …
  • Corporation Bank:戦略・SWOT・企業財務分析
    Corporation Bank - Strategy, SWOT and Corporate Finance Report Summary Corporation Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • FieldPoint Petroleum Corp (FPPP):石油・ガス:M&Aディール及び事業提携情報
    Summary FieldPoint Petroleum Corp (FieldPoint) is an oil and gas company that acquires, operates and develops oil and gas properties. The company’s acquisition includes leasehold and working interests in exploration areas. Its properties comprise South Vacuum field, Block A-49 and Block 6 field, Fly …
  • CITIC Pacific Limited:戦略・SWOT・企業財務分析
    CITIC Pacific Limited - Strategy, SWOT and Corporate Finance Report Summary CITIC Pacific Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Astellas Pharma Inc.:企業のM&A・事業提携・投資動向
    Astellas Pharma Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Astellas Pharma Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆